Farallon Capital Management’s Akero Therapeutics AKRO Stock Holding History

Farallon Capital Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$213K	Buy
2023 Q4	–	Sell
2023 Q3	$202K	Buy
2019 Q3	–	Sell
2019 Q2	$2.87M	Buy